News

Dr. Mehmet Oz, the Administrator of the Centers for Medicare and Medicaid Services, discussed the impending changes to the ...
Trump is changing Medicare, mostly focusing on providers. But the biggest impact may come from tariffs and deporting ...
The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...
Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...
Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...
The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...
The Trump administration is reportedly considering a way to ease Medicare and Medicaid into covering GLP-1 drugs like Ozempic ...
Dave Ramsey explains Medicare and Medicaid, highlighting differences and eligibility. Trump launches health tracking system ...
The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington ...
Washington Post National Health Reporter Paige Winfield Cunningham discusses how the Trump administration is considering ...
Trump appeared unable to keep his eyes open during the conference announcing they were launching a new program that will ...